Management of Latent Tuberculosis Infection in Immigrants
Authors:
- Suzanne M MarksSMSuzanne M Marks
- Kashef IjazKIKashef Ijaz
- Michael F IademarcoMIMichael F Iademarco
- 27 March 2003
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (13) , 1289-1292
Abstract
To the Editor: We applaud the rigorous decision analysis by Khan et al. (Dec. 5 issue),1 who demonstrated the cost effectiveness of screening and treating recent immigrants from countries where tuberculosis is prevalent for latent tuberculosis infection. The investigators also attempted to identify the best treatment regimens for latent tuberculosis infection in various populations from developing countries, on the basis of drug-resistance patterns. However, the differences in direct costs and health benefits among these regimens were relatively small and should be interpreted cautiously. The comparisons were limited, in that the estimates of drug resistance for certain countries (derived from data . . .Keywords
This publication has 10 references indexed in Scilit:
- Global Drug-Resistance Patterns and the Management of Latent Tuberculosis Infection in Immigrants to the United StatesNew England Journal of Medicine, 2002
- Mandatory screening and treatment of immigrants for latent tuberculosis in the USA: just restraint?The Lancet Infectious Diseases, 2001
- Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.2001
- Erroneously Low or Undetectable Plasma Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid Load, Determined by Polymerase Chain Reaction, in West African and American Patients with Non-B Subtype HIV-1 InfectionClinical Infectious Diseases, 2001
- Tuberculosis EliminationAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Comparison of Cost-Effectiveness of Tuberculosis Screening of Close Contacts and Foreign-Born PopulationsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Tuberculosis Screening of Immigrants to Low-Prevalence Countries: A Cost-effectiveness AnalysisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Rifampin Preventive Therapy for Tuberculosis Infection: Experience With 157 AdolescentsAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Rifampin Preventive Therapy for Tuberculosis in Boston's HomelessAmerican Journal of Respiratory and Critical Care Medicine, 1996
- A Double-blind Placebo-controlled Clinical Trial of Three Antituberculosis Chemoprophylaxis Regimens in Patients with Silicosis in Hong KongAmerican Review of Respiratory Disease, 1992